Like many pharmacists employed by drug companies, Rich Douglass visits dozens of doctors every month to tout the benefits of specific medications. Douglass isn't promoting any hot, new brand-name ...

As a followup to the recent Senate Finance Committee hearing on drug pricing, Sen. Steve Daines (R-Mont.) has asked chief executives of two drug makers to explain discrepancies in their responses to a ...

The MedVantx automated ATM-like Sample Management System ("MedStart™") starts patients on generic therapy at the point of care and integrates pharmaceutical sampling data into a patient's health plan ...

Mylan’s complaint centers on its inability to procure samples of Thalomid ® and Revlimid ® from Celgene in order to conduct the bioequivalence testing required for FDA approval of its proposed generic ...

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and ...

The rate at which physicians prescribed generic drugs rose 22 percent among 1,700 physicians nationwide who participated in the first year of a program aimed at promoting generic drug use. The ...

Novel program creates lower cost alternative to onsite pharmacies and provides first ever access to samples of leading generic medications within the worksite clinic setting helping employers cost ...

Fearing that pharmaceutical samples drive up drug spending, health systems in Wisconsin, Washington, and elsewhere have recently told drug representatives that they can no longer hand out samples to ...